Cargando…

A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population

HIV curative strategies currently under development aim to eradicate latent provirus, or prevent viral replication, progression to AIDS, and transmission. The impact of implementing curative programs on HIV epidemics has not been considered. We developed a mathematical model of heterosexual HIV tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimitrov, Dobromir T., Kiem, Hans-Peter, Jerome, Keith R., Johnston, Christine, Schiffer, Joshua T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764923/
https://www.ncbi.nlm.nih.gov/pubmed/26908162
http://dx.doi.org/10.1038/srep22183
_version_ 1782417465204015104
author Dimitrov, Dobromir T.
Kiem, Hans-Peter
Jerome, Keith R.
Johnston, Christine
Schiffer, Joshua T.
author_facet Dimitrov, Dobromir T.
Kiem, Hans-Peter
Jerome, Keith R.
Johnston, Christine
Schiffer, Joshua T.
author_sort Dimitrov, Dobromir T.
collection PubMed
description HIV curative strategies currently under development aim to eradicate latent provirus, or prevent viral replication, progression to AIDS, and transmission. The impact of implementing curative programs on HIV epidemics has not been considered. We developed a mathematical model of heterosexual HIV transmission to evaluate the independent and synergistic impact of ART, HIV prevention interventions and cure on HIV prevalence and incidence. The basic reproduction number was calculated to study the potential for the epidemic to be eliminated. We explored scenarios with and without the assumption that patients enrolled into HIV cure programs need to be on antiretroviral treatment (ART). In our simulations, curative regimes had limited impact on HIV incidence if only ART patients were eligible for cure. Cure implementation had a significant impact on HIV incidence if ART-untreated patients were enrolled directly into cure programs. Concurrent HIV prevention programs moderately decreased the percent of ART treated or cured patients needed to achieve elimination. We project that widespread implementation of HIV cure would decrease HIV prevalence under all scenarios but would only lower rate of new infections if ART-untreated patients were targeted. Current efforts to identify untreated HIV patients will gain even further relevance upon availability of an HIV cure.
format Online
Article
Text
id pubmed-4764923
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47649232016-03-02 A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population Dimitrov, Dobromir T. Kiem, Hans-Peter Jerome, Keith R. Johnston, Christine Schiffer, Joshua T. Sci Rep Article HIV curative strategies currently under development aim to eradicate latent provirus, or prevent viral replication, progression to AIDS, and transmission. The impact of implementing curative programs on HIV epidemics has not been considered. We developed a mathematical model of heterosexual HIV transmission to evaluate the independent and synergistic impact of ART, HIV prevention interventions and cure on HIV prevalence and incidence. The basic reproduction number was calculated to study the potential for the epidemic to be eliminated. We explored scenarios with and without the assumption that patients enrolled into HIV cure programs need to be on antiretroviral treatment (ART). In our simulations, curative regimes had limited impact on HIV incidence if only ART patients were eligible for cure. Cure implementation had a significant impact on HIV incidence if ART-untreated patients were enrolled directly into cure programs. Concurrent HIV prevention programs moderately decreased the percent of ART treated or cured patients needed to achieve elimination. We project that widespread implementation of HIV cure would decrease HIV prevalence under all scenarios but would only lower rate of new infections if ART-untreated patients were targeted. Current efforts to identify untreated HIV patients will gain even further relevance upon availability of an HIV cure. Nature Publishing Group 2016-02-24 /pmc/articles/PMC4764923/ /pubmed/26908162 http://dx.doi.org/10.1038/srep22183 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Dimitrov, Dobromir T.
Kiem, Hans-Peter
Jerome, Keith R.
Johnston, Christine
Schiffer, Joshua T.
A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population
title A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population
title_full A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population
title_fullStr A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population
title_full_unstemmed A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population
title_short A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population
title_sort curative regimen would decrease hiv prevalence but not hiv incidence unless targeted to an art-naïve population
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764923/
https://www.ncbi.nlm.nih.gov/pubmed/26908162
http://dx.doi.org/10.1038/srep22183
work_keys_str_mv AT dimitrovdobromirt acurativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT kiemhanspeter acurativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT jeromekeithr acurativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT johnstonchristine acurativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT schifferjoshuat acurativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT dimitrovdobromirt curativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT kiemhanspeter curativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT jeromekeithr curativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT johnstonchristine curativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation
AT schifferjoshuat curativeregimenwoulddecreasehivprevalencebutnothivincidenceunlesstargetedtoanartnaivepopulation